Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

2.5K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K
Odds Ratio01:09

Odds Ratio

2.3K
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
2.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
Hazard Ratio01:12

Hazard Ratio

756
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
756
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.7K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fatigue, neurological, and cognitive symptoms after COVID-19 - a nationwide matched cohort study in Denmark.

Infectious diseases (London, England)·2026
Same author

An Overview and Recent Developments in the Analysis of Multistate Processes.

Statistics in medicine·2026
Same author

Genetic confounding in the associations between maternal health and autism.

medRxiv : the preprint server for health sciences·2026
Same author

Maternal health and autism risk: parsing direct and indirect genetic effects using 3-generation family linkage.

medRxiv : the preprint server for health sciences·2026
Same author

Censoring and Competing Risks: Avoidable and Non-Avoidable Events. Comment to the Article "Hazards constitute key quantities for analysing, interpreting and understanding time-to-event data" by Beyersmann, Schmoor, and Schumacher.

Biometrical journal. Biometrische Zeitschrift·2025
Same author

Cross-Setting Replication of the Associations Between Maternal Health and Autism.

Journal of the American Academy of Child and Adolescent Psychiatry·2025
Same journal

Shared frailty sieve estimation for dependent left truncated and interval censored data.

Lifetime data analysis·2026
Same journal

Functional win-fractions regression models for composite outcomes.

Lifetime data analysis·2026
Same journal

Variable selection in causal semiparametric transformation models with all-or-nothing treatment compliance.

Lifetime data analysis·2026
Same journal

Correction to: A uniformisation-driven algorithm for inference-related estimation of a phase-type ageing model.

Lifetime data analysis·2026
Same journal

Unobserved heterogeneity in threshold regression based on the hitting times of a reflected Brownian motion for recurrent hypoglycemia.

Lifetime data analysis·2026
Same journal

Variable selection with broken adaptive ridge regression for interval-censored competing risks data.

Lifetime data analysis·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K

Events per variable for risk differences and relative risks using pseudo-observations.

Stefan Nygaard Hansen1, Per Kragh Andersen, Erik Thorlund Parner

  • 1Section for Biostatistics, University of Aarhus, Bartholins Allé 2, 8000 , Aarhus C, Denmark, stefanh@biostat.au.dk.

Lifetime Data Analysis
|January 15, 2014
PubMed
Summary
This summary is machine-generated.

This study evaluates a pseudo-observation method for analyzing censored survival data. It found that the number of events per variable significantly impacts the accuracy of risk difference and relative risk estimates in regression models.

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K

Related Experiment Videos

Last Updated: May 4, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K

Area of Science:

  • Biostatistics and Survival Analysis
  • Statistical Modeling for Clinical Data

Background:

  • Pseudo-observation methods enable direct regression modeling of survival data functionals.
  • Standard generalized estimating equation software can fit these models.
  • Regression models face challenges with high covariate numbers relative to observed events.

Purpose of the Study:

  • To assess the small sample performance of the pseudo-observation method for right-censored data.
  • To investigate the estimation of risk differences and relative risks using this method.
  • To examine the influence of sample size, variable count, and events per variable on estimator accuracy.

Main Methods:

  • Conducted a simulation study to evaluate the pseudo-observation method.
  • Focused on right-censored data and competing risks scenarios.
  • Analyzed coverage probabilities and relative bias of estimators under varying conditions.

Main Results:

  • The simulation demonstrated that the number of events per variable is a critical factor.
  • Coverage probabilities and relative bias are sensitive to sample size and covariate load.
  • The pseudo-observation method's reliability is contingent on adequate events per variable.

Conclusions:

  • The pseudo-observation method requires careful consideration of the events per variable rule.
  • Simulation results provide guidance for applying regression models to censored survival data.
  • This study highlights the importance of sample size and covariate balance for accurate risk estimation.